ICD-10 Coding for Turner Syndrome(E03.9U, E23.0U, Q25.1U)
Comprehensive guide on Turner syndrome ICD-10 coding, including specific codes for different karyotypes, documentation requirements, and coding pitfalls.
Complete code families applicable to Turner Syndrome
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| Q96.0 | Turner syndrome, 45,X | Use when karyotype analysis confirms 45,X. |
|
| Q96.3 | Turner syndrome, mosaicism 45,X/46,XX | Use when mosaicism is confirmed via karyotype analysis. |
|
| Q96.9 | Turner syndrome, unspecified | Use when karyotype is not available or pending. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutTurner Syndrome
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Turner Syndrome.
Failure to document karyotype
Impact
Clinical: May lead to inappropriate treatment plans., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims.
Mitigation
Ensure karyotype testing is completed and documented., Educate staff on importance of detailed documentation.
Using Q96.9 when karyotype is known
Impact
Reimbursement: May lead to incorrect DRG assignment and reimbursement issues., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of clinical data.
Mitigation
Use specific codes like Q96.0 or Q96.3 based on karyotype results.
Karyotype Documentation
Impact
Lack of specific karyotype documentation can lead to audit issues.
Mitigation
Ensure all Turner syndrome diagnoses include karyotype results.